Abstract
Baseline patient characteristics, physician-assessed effectiveness, patient-reported outcomes, and safety in adult and adolescent patients with atopic dermatitis in France treated with dupilumab: Real-world insights 1 year into the GLOBOSTAD multinational prospective observational study
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
